Cansino Biologics Inc (688185) — Capital Reinvestment Ratio
Cansino Biologics Inc (688185) has a Capital Reinvestment Ratio of 1.45x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥30.53 Million) in capital expenditures (CN¥44.23 Million). Check 688185 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cansino Biologics Inc Capital Reinvestment Ratio (2021–2025)
This chart tracks Cansino Biologics Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see how efficiently does Cansino Biologics Inc generate cash.
Annual Capital Reinvestment Ratio for Cansino Biologics Inc (2021–2025)
Year-by-year Capital Reinvestment Ratio for Cansino Biologics Inc from 2021 to 2025. See Cansino Biologics Inc (688185) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.13x | CN¥77.86 Million | CN¥243.90 Million | ▲ +424.5% |
| 2021 | 0.60x | CN¥2.01 Billion | CN¥1.20 Billion | — |